AnalystsBill MaughanBill Maughan's Stock Forecasts
AnalystsBill Maughan
Sectors:
Industries:
Analyst Ranking
Top 36%
#1636 out of 4572 analysts
Average Return
+6.42%
Win Rate
44%4 out of 9
Risk vs Reward
Poor
Good
Bill Maughan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +116.50% | $21.94 | $47.50 | 2023-11-01 - 2024-05-02 | Strong Buy |
Bicycle Therapeutics PLCBCYC | +6.42% | $23.20 | $24.69 | 2024-02-20 - 2024-05-02 | Strong Buy |
Biontech SeBNTX | +1.10% | $91.24 | $92.24 | 2024-02-19 - 2024-05-02 | Strong Buy |
Biontech SeBNTX | +0.27% | $91.99 | $92.24 | 2024-03-20 - 2024-05-02 | Strong Buy |
Bill Maughan Analyst Color
Get additional color on Bill Maughan's coverage of popular stocks
Bill Maughan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nkarta IncNKTX | 1 | Strong Buy | $16.00 | +112.48% | Maintains | a month ago |
Biontech SeBNTX | 4 | Strong Buy | $171.00 | +85.39% | Reiterates | a month ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $24.00 | +700.00% | Maintains | 2 months ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $26.00 | +50.72% | Maintains | 2 months ago |
Immunocore Holdings PLCIMCR | 2 | Hold | $63.00 | +5.95% | Maintains | 2 months ago |
Moderna IncMRNA | 2 | Hold | $91.00 | -27.54% | Maintains | 2 months ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $60.00 | +143.01% | Reiterates | 2 months ago |
Merus NvMRUS | 1 | Strong Buy | $45.00 | -5.26% | Initiates Coverage On | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.